AI Insights: Qualitative Analysis of UTI Decisions

The PLOS One study on general practitioners’ perspectives, published on November 11, 2026, found that antibiotic-sparing UTI care is a conditional, negotiated process rather than a single prescribing decision.

• The study interviewed 15 general practitioners in Switzerland between June 10 and July 17, 2025, and identified six themes in the thematic analysis.
• The interviews lasted a mean of 44 minutes, with a range of 32 to 54 minutes, according to the November 11, 2026 PLOS One study.
• The participating general practitioners had a mean age of 46.6 years, 53.3% were female, and their general practice experience ranged from 5 to 25 years.
• The study found that symptoms, patient expectations, trust, time pressure, practice workflows, professional autonomy, and pharmacy communication influenced UTI treatment decisions.
• AI-enabled qualitative analysis can help researchers compare themes across interviews and stakeholder groups, but clinical interpretation, ethical judgment, and final conclusions require human oversight.

The November 11, 2026 PLOS One study found that most interviewed general practitioners had experience with antibiotic-sparing strategies, including symptomatic treatment and delayed or backup prescribing.

The study reported that prescribing thresholds varied between general practitioners. Clinical factors, symptom duration, patient expectations, trust, diagnostic findings, access to follow-up, and practical workload all shaped the decision.

The study’s six themes covered conditional antibiotic-sparing intentions, trust and expectations, practical constraints, practice staff involvement, professional autonomy, and the partial visibility of pharmacy-based care.

One general practitioner summarized the implementation gap by saying, “By now, the antibiotic-sparing approach is actually the approach of choice in our practice... However, it is still often the case that aspiration and reality are very far apart.” The quotation appears in the study as the account of GP10.

The PLOS One researchers reported that later interviews produced no substantively new content relevant to the research questions after 15 interviews. The authors also noted that the study was exploratory and focused only on general practitioners, not patients, pharmacists, or non-physician medical staff.

Healthcare qualitative researchers should analyze UTI treatment decisions across the full care pathway, because the November 11, 2026 PLOS One study found that decisions were influenced before, during, and after the general practitioner consultation.

The study indicates that a coding framework limited to antibiotic prescribing would miss important mechanisms. Patient expectations and trust affected shared decision-making, while time pressure and weekend access affected backup prescribing. Practice staff influenced triage, testing, counselling, and care navigation, while pharmacy-based care was often only partly visible to general practitioners.

The findings also show why cross-segment analysis matters. A healthcare research team could compare themes by role, such as general practitioner, pharmacist, practice assistant, and patient, or by context, such as routine consultation, high workload, delayed presentation, and limited follow-up access.

One GP described the coordination problem directly: “What’s needed is a consensus among physicians and a shift in societal thinking.” The PLOS One study attributes this quotation to GP9.

The study also reported a data-protection constraint: full interview transcripts were not publicly available because detailed qualitative data could permit deductive identification of participants despite pseudonymisation. Researchers using AI for qualitative analysis should therefore prioritize secure processing, controlled access, and transparent documentation of analytical decisions.

The November 11, 2026 PLOS One study shows that antibiotic-sparing UTI management is shaped by more than the prescribing moment. Qualitative analysis must account for patient expectations, trust, time pressure, practice staff, professional boundaries, and communication with pharmacies.

AI-enabled analysis can help healthcare research teams organize interview evidence, compare stakeholder segments, and surface patterns faster, while researchers remain responsible for interpretation, ethics, and clinical meaning. Evidano brings these capabilities together for document-based qualitative research, including thematic and cross-segment analysis.

To analyze healthcare interviews and other qualitative datasets with Evidano, try Evidano for free.